首頁 › 多發性骨髓瘤 › 伊利諾 › Springfield
Springfield, IL 的 多發性骨髓瘤 臨床試驗
4 項針對 多發性骨髓瘤 的研究正在 Springfield（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
招募中2 期
- Southern Illinois University School of Medicine, Springfield
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
招募中3 期
- Simmons Cancer Institute at SIU, Springfield
- Springfield Clinic Main Campus, Springfield
- HSHS St. John's Hospital, Springfield
- 還有 1 項
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
招募中3 期
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
招募中3 期
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Memorial Medical Center, Springfield
其他城市的 多發性骨髓瘤 試驗
- New York City, NY60 項研究
- Boston, MA42 項研究
- Atlanta, GA41 項研究
- Houston, TX38 項研究
- Durham, NC37 項研究
- Nashville, TN32 項研究
- Denver, CO27 項研究
- Rochester, MN24 項研究
- St. Louis, MO24 項研究
- Columbus, OH24 項研究
- Baldwin Park, CA23 項研究
- Chicago, IL22 項研究
Springfield 的其他研究
- 非小細胞肺癌13 項研究
- 肺癌12 項研究
- 大腸直腸癌9 項研究
- 急性髓系白血病8 項研究
- 乳癌8 項研究
- 頭頸部鱗狀細胞癌6 項研究
- 腎臟癌（腎細胞癌）6 項研究
- 前列腺癌6 項研究
- 癌症（所有類型）6 項研究
- 膀胱癌6 項研究
- 胰臟癌5 項研究
- 黑色素瘤5 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。